Pelthos Therapeutics Inc. Variable Lease, Cost
Pelthos Therapeutics Inc. (PTHS) reported Variable Lease, Cost of $38.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-13
- Pelthos Therapeutics Inc. variable lease, cost for the quarter ending 2026-03-31 was $38.00K.
- Pelthos Therapeutics Inc. variable lease, cost for fiscal 2025 was $75.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 12 month |
|---|---|---|
| 2026-03-31 | $38.00K 10-Q/A · filed 2026-08-13 | |
| 2025-12-31 | $75.00K 10-K · filed 2026-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |